AccuShares (R) Investment Management, LLC ("AccuShares")

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
AccuShares (R) Investment Management, LLC ("AccuShares") Announces an Estimated Regular Distribution and, if Applicable, an Estimated Net Income Distribution for AccuShares Spot CBOE(R) VIX(R) Up Shares and Down Shares

STAMFORD, CT --(Marketwired - September 08, 2015) - AccuShares, as sponsor of the AccuShares Commodities Trust I (the "Trust"), today announces an estimated Regular Distribution and, if applicable, an estimated Net Income Distribution for AccuShares Spot CBOE VIX Up Shares ( NASDAQ : VXUP ) (the "Up Shares") and Spot CBOE VIX Down Shares ( NASDAQ : VXDN ) (the "Down Shares"). AccuShares also announces a Corrective Distribution followed by a Reverse Split for Up Shares and Down Shares. The terms Regular Distribution, Net Income Distribution, Corrective Distribution and Reverse Split are defined and described in the current prospectus of the AccuShares Spot CBOE VIX Fund (the "Fund").

The estimated distribution amounts below are calculated as of September 8, 2015 and therefore such information is only an estimate, is subject to change and may be significantly different from the actual distribution amounts to be declared, which will be published on the date of declaration. The estimated distribution information below has been determined as if the closing value of the CBOE Volatility Index ® (the "Underlying Index") for September 8, 2015 were the closing value of the Underlying Index at the end of the current Regular Distribution measurement period.

The relevant estimated distribution information is provided in the tables below:

Distribution Dates :

         
NASDAQ Ticker Name Ex-Date Record Date Distribution Payment Date
VXUP AccuShares Spot CBOE VIX Up Shares September 16, 2015 September 18, 2015 September 22, 2015
VXDN AccuShares Spot CBOE VIX Down Shares September 16, 2015 September 18, 2015 September 22, 2015
         

Estimated Distribution Amount Information :

               
NASDAQ Ticker Name Closing Index Value as of September 8, 2015 Post- Distribution Share Index Factor* Post- Distribution Class Value per Share* Net Income Distribution Amount per share Regular Distribution Amount per share Corrective Distribution Amount per share
VXUP AccuShares Spot CBOE VIX Up Shares 24.90 0.02991968 $0.74 $0.000000 $0.000000 1 Down Share
VXDN AccuShares Spot CBOE VIX Down Shares 24.90 -0.02991968 $0.74 $0.000000 $0.470145 1 Up Share
               

* As defined in the Fund's prospectus.

Estimated Distribution Amount Information (continues): AccuShares also announces a Reverse Split that will take place after the Regular, Net Income, and Corrective Distributions to holders of record on record date. The Corrective Distribution and Reverse Split will affect the class value per share of both the Up Shares and Down Shares, but it will not impact the value of a shareholder's holdings in the Fund.

More information about the Fund can be found at the Trust's website at www.accushares.com .

Investor Reassessment:

Investors wishing to maximize exposure to the index tracked by the Fund, the CBOE Volatility Index, in either direction or investors wishing to compound gains over one or more distribution dates must invest any cash distributed, and sell any shares distributed and invest the sale proceeds thereof, in the class of shares aligned with their investment objectives.

The Fund has been designed to be utilized by investors who are prepared to reassess their holding of the Fund's shares at least as frequently as each distribution date. Investors in the Fund who wish to maintain a maximum exposure, a targeted absolute exposure, or a targeted relative exposure to the Underlying Index over multiple distribution dates should reassess their positions following all cash and share distributions, and all Fund resets relating to the Share Index Factors. The Fund will not compound investor gains or otherwise rebalance investor positions to maximize investor exposure. The Fund is designed to make Regular Distributions of cash and in some cases shares to facilitate regular distribution of investor gains and to promote a deliberate and regular reassessment by investors of their investment in the Fund.

Investors who hold shares over one or more consecutive distribution dates without reassessment of their Fund share portfolio may experience decreased exposure to the Underlying Index as well as a reduced opportunity for gain and loss.

About AccuShares: Founded in 2011, AccuShares ( www.accusharesinvmgmt.com ) is an innovative financial services firm sponsoring exchange traded products ("ETPs") that provide direct access to "spot" indices in key alternative asset classes, including volatility. AccuShares ETPs offer investors the ability to trade both shares that are positively linked with the ETP's index ("Up Shares") and shares that are negatively linked with such index ("Down Shares"), enabling them to potentially take advantage of opportunity in any market. AccuShares' patent-pending technology and "direct-to-index" quantitative design seeks to reduce overall expenses while also attempting to both simplify tax reporting and provide investors with a predictable cost of ownership and transparency in returns.

Disclosures: Neither the Trust nor the Fund is an investment company within the meaning of the Investment Company Act of 1940 and neither is subject to regulation thereunder. Although AccuShares is registered as a commodity pool operator with the Commodity Futures Trading Commission ("CFTC"), the Trust and the Fund are not subject to regulation under the Commodities Exchange Act or by the CFTC. Consequently Fund shareholders are not afforded the regulatory protections provided to investors in registered investment companies or commodity pools.

Investing in the Funds involves substantial risk and high volatility, including possible loss of principal. Shares of the Fund are intended for sophisticated, professional and institutional investors. The Fund is not intended to be used as a long-term passive investment vehicle and should be used by investors who understand the risks of the volatility market. Investors expecting the Underlying Index to decline should purchase the Fund's Down Shares, and investors expecting the Underlying Index to increase should purchase the Fund's Up Shares, to align their respective Fund investments with their respective expectations. Please read the Fund's prospectus carefully before investing. The Fund's prospectus can be obtained by clicking the link below.

http://www.accushares.com/resources/vix-fund-prospectus

The Trust is a Delaware statutory trust organized by AccuShares into separate fund series. The Fund's shares represent fractional undivided interests in and ownership of the Fund only and not any other series of the Trust or the Trust as a whole. The Fund offers its shares on a continuous basis and is listed on the NASDAQ.

Disclaimers: The Fund is not sponsored, endorsed, sold or promoted by S&P Dow Jones Indices LLC (the "Index Provider"), Dow Jones Trademark Holdings LLC ("Dow Jones"), Standard & Poor's Financial Services LLC ("S&P"), their respective affiliates or their third party licensors (including The Chicago Board Options Exchange Incorporated ("CBOE")) and none of such parties make any representation or warranty, express or implied, regarding the advisability of investing in securities generally or in the Fund particularly, or the ability of the Underlying Index or any related indices or sub-indices to track the appropriate market performance, or as to the results to be obtained by the Trust, the Fund, the Fund's shareholders or any other person or entity from use of the Underlying Index or any data included therein. None of such parties have any liability for any errors, omissions, or interruptions in the Underlying Index or such data, and the Index Provider and CBOE do not guarantee the accuracy or the completeness of the Underlying Index or such data. Neither the Index Provider nor CBOE make any express or implied warranties, and expressly disclaim all warranties of merchantability or fitness for a particular purpose or use with respect to the Underlying Index or such data. Without limiting any of the foregoing, the Index Provider, Dow Jones, S&P, CBOE, their affiliates and third party licensors expressly disclaim any and all liability for any special, punitive, indirect, or consequential damages (including lost profits), even if notified of the possibility of such damages.

The only relationship of the Index Provider, CBOE, their affiliates or their third party licensors to AccuShares, the trustee of the Trust (the "Trustee"), the Trust or the Fund is the licensing of certain trademarks, trade names and service marks and of the Underlying Index, which is constructed, calculated and published by CBOE, and has been licensed by the Index Provider, without regard to AccuShares, the Trustee, the Trust or the Fund. Neither AccuShares, nor the Trustee, nor the Trust, nor the Fund has any contractual relationship or other arrangement with CBOE with respect to the use of the Underlying Index and related intellectual property. Instead, the rights of AccuShares, the Trust and the Fund to utilize the Underlying Index and related intellectual property is derivative of the rights of the Index Provider under its agreement with CBOE. CBOE has no obligation to take the needs of AccuShares, the Trustee, the Trust, the Fund or the Fund's shareholders into consideration in determining, composing or calculating the Underlying Index.

Neither the Index Provider, CBOE, nor any of their respective affiliates or third party licensors is responsible for or has participated in the determination of the timing, price or quality of the shares issued by the Fund or in the determination or calculation of the equation by which the shares are to be converted into cash. Neither the Index Provider, CBOE, nor any of their respective affiliates or third party licensors shall have any obligation or liability, including, without limitation, to Fund investors, in connection with the administration, marketing or trading of the Fund.

The Underlying Index is a product of CBOE, which is licensed by the Index Provider or its affiliates to AccuShares in connection with the operation of the Fund. Standard & Poor's ® and S&P ® are registered trademarks of S&P; Dow Jones ® is a registered trademark of Dow Jones; CBOE ® , Chicago Board Options Exchange ® , CBOE Volatility Index ® and VIX ® are registered trademarks of CBOE; and these trademarks have been licensed for use by the Index Provider and sublicensed for certain purposes by AccuShares. AccuShares ™ is a trademark of AccuShares Holdings LLC.

Mo Shafroth Peppercomm (212) 931.6100 accushares@peppercomm.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Patriot Growth Welcomes Rajeev Jain: Operational Excellence

Updated Category News Views 89

Shifting Gears: Patriot Growth's New Leadership Turn When it comes to tightening the ship and pointing towards uncharted waters, new leadership can be the key. This couldn't be more true for Patriot Growth Insurance Services as they welcome Rajeev Jain aboard as their latest Chief Operating Officer. This move is all about reinforcing their commitment to operational...

Continue Reading
Philanthropy in Focus: Town & Country's Star-Studded Day

Updated Category News Views 53

An Annual Celebration of Generosity Town & Country, marking 180 years of observing the social highs and lows, just wrapped up its 13th Annual Philanthropy Summit at Hearst Tower. This wasn't your run-of-the-mill event where you sit and awkwardly sip bad coffee. When you've got high-profile names like Tory Burch and Russell Wilson in the same room, you know it’s a...

Continue Reading
Multiplier's Data Signals Global Hiring Evolution

Updated Category News Views 23

Shaking Up the Global Hiring Playbook You think you know how hiring works globally? Think again. Based on data from a whopping 38,000 cross-border hires, Multiplier's latest Talent Trends has spilled some hot new beans on how companies are rethinking their talent acquisition strategies. This isn’t just some thumb-twiddling speculation either—it’s grounded in real...

Continue Reading
Microplastics Found in Human Blood: Alarming Evidence

Updated Category News Views 106

An Unsettling Discovery in Our Veins Microplastics in the blood? Yep, you read that right, and it’s not some sci-fi horror story—it’s today’s harsh reality. A riveting report from the likes of the Plastic Pollution Coalition and the Canadian Association of Physicians for the Environment has thrown a bucket of cold water on us. They uncovered microplastics in 96%...

Continue Reading
Greek-Serbian Heads Meet to Prep for 2027 Tourism Expo

Updated Category News Views 15

Breaking Cultural and Business Barriers You ever get that feeling when two neighbors finally decide to have a proper sit-down and hash things out? That's the vibe in Athens today, as Greek and Serbian movers and shakers are gathering to lay the groundwork for EXPO 2027 Belgrade. It's a match that's kinda hard to ignore if you're watching Europe's trade routes—especially...

Continue Reading
Northern.tech Enhances Product Software Control & Security

Updated Category News Views 114

The Evolution of Product Software Management Over in Palo Alto, Northern.tech has just flipped the switch on something pretty significant—component orchestration in their Mender solution. This isn't just your run-of-the-mill software update. They're talking about managing software across the entire system of a connected product. You know, pulling all the strings at...

Continue Reading
Radius Global Rebrands to Unite Infrastructure Investments

Updated Category News Views 0

Changing Gears to Navigate Global Connectivity Alright, buckle up because Radius Global Infrastructure, Inc. is making a move that’ll reshape how they play the digital infrastructure game. As of October 28, 2026, they’ve wrapped APWireless into their fold, waving goodbye to separate identities and hello to a unified brand. If you’ve got a finger in the tech pie,...

Continue Reading
CELSET Unveils SOLTOX: Expanding in Global Markets

Updated Category News Views 9

New Contender in the Global Botulinum Toxin Arena Launching a fresh player onto the international stage, CELSET INC. from Seoul throws down with SOLTOX, their own botulinum toxin Type A brand. This ain't your run-of-the-mill roll-out; it's another notch for Korean biotech trying to snag a piece of global market action. A Look at SOLTOX's Technical Makeup We’re talking...

Continue Reading
New Ambulatory Surgery Center in Alabama Breaks Ground

Updated Category News Views 18

Breaking New Ground: USOP and SOS Lead the Charge You can almost hear the construction noise starting up in Montgomery, Alabama, where U.S. Orthopaedic Partners (USOP) and Southern Orthopaedic Surgeons (SOS) have just launched an ambitious new project. They're not just cutting ceremonial ribbons; they're slicing into the future of orthopedic care in Central Alabama. The...

Continue Reading
Beta Bionics Lawsuit: What Investors Need to Know

Updated Category News Views 43

Beta Bionics Takes a Hit: What's Behind the Drop? You ever have one of those moments where you wonder if you missed a memo? Well, folks investing in Beta Bionics (NASDAQ:BBNX) sure might feel that way after a staggering 37% plunge in their stock. The issue here isn't just the drop—it's what spurred it: a securities class action lawsuit alleging some murky disclosures...

Continue Reading

Top 5 Most Recently Viewed Articles

Kitron Expands Footprint in U.S. Defense Electronics Market

Updated Category News Views 206

Kitron Receives Significant Order from U.S. Army In a major development, Kitron has secured a significant order that promises to enhance its presence in the U.S. defense sector. This order, valued at over USD 5 million annually, presents an exciting opportunity for Kitron to deliver advanced custom electronics tailored for the U.S. Army and allied forces. Production Plans...

Continue Reading
Nvidia Leads Tech Market: Analysts Anticipate 2026 Surge

Updated Category News Views 316

Nvidia's Lead in the Tech Arena Dan Ives, Managing Director at Wedbush Securities, offers a compelling perspective on the current evolution of the technology sector. He suggests that Nvidia Corp. is not just a player but rather a dominant force in the artificial intelligence (AI) revolution. Ives expressed a bold assertion, stating, "At the end of the day, it’s...

Continue Reading
Michael Saylor's Debate on Trump and Harris: Who's the Bitcoin Champion?

Updated Category News Views 377

The Crypto-Politics Landscape Ahead of Election As the presidential election approaches, discussions around cryptocurrency are heating up, particularly the role of Bitcoin in politics. Michael Saylor, founder of MicroStrategy, has become a prominent voice in this arena. He sparked a debate among his followers regarding who would best support Bitcoin: former President...

Continue Reading
Novo Nordisk's Wegovy Trial Success: Weight Loss Breakthrough

Updated Category News Views 760

Groundbreaking Results from Novo Nordisk's Wegovy® Trial The latest findings from Novo Nordisk indicate a significant breakthrough in weight management through the higher dose of Wegovy, which has delivered an impressive average weight loss of 21% for individuals suffering from obesity. The trial results, presented at a prominent diabetes conference, revealed that...

Continue Reading
Insider Trading Insights: Merit Medical's Recent Stock Sale

Updated Category News Views 134

Recent Insider Trading Activity at Merit Medical Systems On a recent day, it was revealed through an SEC filing that Fred Lampropoulos, the Executive Chairman of Merit Medical Systems (NASDAQ:MMSI), made a noteworthy insider sale. Details of the Insider Sale Lampropoulos decided to sell 5,000 shares of the company, as documented in a Form 4 filing with the U.S. Securities...

Continue Reading